This talk discusses the latest developments in psychotropic drugs for the treatment of conditions ranging from psychosis to attention-deficit/hyperactivity disorder (ADHD). The benefits and drawbacks of first- and second-generation antipsychotic drugs, including long-acting injectable formulas, are examined. The responsible prescribing of stimulants to patients with autism spectrum disorder and ADHD is also addressed. This session also features a rigorous examination of current trends in benzodiazepine use, with detailed guidance on how to avoid withdrawal syndromes.
This session includes information on the following topics:
- Causes and pharmacologic treatment of dementia
- Developments in the management of psychosis for pediatric and adolescent patients
- Monitoring for abuse in patients taking stimulants and gabapentinoids
- Updated treatment agents for insomnia and sleep disorders